Reteta vs RevMaxx (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

Two small scribes that treat coding as part of the job rather than as a downstream problem, generating structured notes with diagnosis and procedure codes attached. For a small practice without a dedicated coder that is a real proposition, because the gap between a finished note and a submitted claim is where independent practices lose money. The two are close enough on paper that the honest advice is to pilot both on your own specialty and see which needs less correction. What neither publishes is the thing that should worry a buyer: no accuracy figure, no add to delete ratio, and no audit result showing the suggested codes were justified. A tool that raises your coding level looks identical to a tool that raises your audit exposure until someone checks, and the vendor will not be the party answering for it.

The case for Reteta
  • Coding is handled alongside documentation in one pass, generating structured notes with the diagnosis and procedure codes attached rather than leaving the coding to a second system.
  • For a small practice without a coder, having the codes arrive with the note is the difference between billing this week and billing next month.
  • A single product covering both removes the reconciliation step where documentation and codes drift apart.
The case for RevMaxx
  • It arrived from a longer development cycle with venture backing behind it, which for a small vendor is a signal about how long the product is likely to be maintained.
  • The scribe and coding combination is the same shape, so the comparison comes down to fit and support rather than to capability on paper.
  • For a practice evaluating both, the deciding factor is usually which one handles your specialty's documentation without constant correction.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Reteta and RevMaxx are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Reteta RevMaxx
Primary category Ambient Scribes Ambient Scribes
Founded 2024 Not recorded
Headquarters Cranbury, New Jersey Tampa, Florida, United States
Website reteta.com revmaxx.co
Attribute Matrix

Side by Side

Axis
R
Reteta
R
RevMaxx
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

Reteta

The AI Health Index awards Reteta its top capability grade on AI Centrality. Set against RevMaxx, Reteta does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

RevMaxx

The AI Health Index awards RevMaxx its top capability grade on AI Centrality, HIPAA and BAA Posture and Commercial Transparency. Set against Reteta, RevMaxx grades higher on HIPAA and BAA Posture and Commercial Transparency. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose Reteta or RevMaxx?

The AI Health Index grades RevMaxx higher than Reteta on every axis that separates them, HIPAA and BAA Posture and Commercial Transparency. Reteta does not grade higher on any scored axis.

Where do Reteta and RevMaxx differ most?

The widest separation the AI Health Index records between Reteta and RevMaxx is on Commercial Transparency, where Reteta grades C and RevMaxx grades A. That axis sits in the Commercial group, so it should carry the most weight for a buyer whose binding constraint is contracting, scope and what the price actually covers.

Where do Reteta and RevMaxx grade the same?

The AI Health Index grades Reteta and RevMaxx the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

What have Reteta and RevMaxx not disclosed?

At the last review, at least one of Reteta and RevMaxx published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.

Disclosure

Both vendors market improved coding capture alongside documentation, which is the coding gradient in its most direct form: a product that suggests more codes raises revenue whether or not the codes are justified, and neither publishes an audit result, an add to delete ratio or an accuracy figure for its suggestions. Neither publishes a security attestation, retention schedule or subprocessor list, and neither has a published study, third party rating or named deployment. For any practice adopting either, the question to settle first is who is accountable if a payer audit finds the generated codes unsupported, because the answer is not the vendor.